Markets
Moderna Settles $2.25 Billion Patent Dispute, Shares Jump 10% on Legal Clarity
The biotech resolves a long-running lipid nanoparticle infringement case with Arbutus and Genevant, clearing a path for its post-COVID vaccine portfolio.
7 min read
·